Cataract device safety check: 20-Month Follow-Up study launches
Disease control
ENROLLING_BY_INVITATION
This study follows 61 people who previously used the REVISYON SDS 100 device for mild-to-moderate cataract. Researchers will track side effects and vision changes over about 20 months to see if the device remains safe and effective. Participants do not receive any new treatment—o…
Sponsor: Edinburgh Biosciences Ltd • Aim: Disease control
Last updated May 13, 2026 16:03 UTC